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Abstract
In preclinical positron emission tomography (PET) studies an anaesthetic is used to ensure that the animal
does not move during the scan. However, anaesthesia may have confounding effects on the drug or tracer
kinetics under study, and the nature of these effects is usually not known. We have implemented a protocol for
tracking the rigid motion of the head of a fully conscious rat during a PET scan and performing a motion
compensated list-mode reconstruction of the data. Using this technique we have conducted eight rat studies to
investigate the effect of isoflurane on the uptake of 18F-FDG in the brain, by comparing conscious and
unconscious scans. Our results indicate that isoflurane significantly decreases the whole brain uptake, as well as
decreasing the relative regional FDG uptake in the cortex, diencephalon, and inferior colliculi, while increasing
it in the vestibular nuclei. No statistically significant changes in FDG uptake were observed in the cerebellum
and striata.
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1 Introduction
In preclinical positron emission tomography (PET)
studies an anaesthetic, such as isoflurane, ketamine, or
chloral hydrate, etc., is usually used to ensure that the
animal remains motionless for the duration of the scan.
The effect of the anaesthetic on the kinetics of the drug
or radioactive tracer under study is not always known,
and may confound the results of the investigation. This
is especially problematic for translational studies since
anaesthesia is usually avoided in the clinic. A summary
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of reports on the effect of anaesthetics in preclinical
studies is given in [1] and [2]. In general three meth-
ods are used preclinically to establish the effect of an
anaesthetic. The first is to compare the findings of sim-
ilar investigations using different anaesthetics [3], how-
ever inferring the individual effects of the anaesthetics
separately is complex and difficult to verify. The sec-
ond method is to infuse the animals with the tracer or
drug while conscious and then, after some time, anaes-
thetise and scan them, thus acquiring a static scan
where the tracer or drug metabolism is not affected
by the anaesthetic [4]; this assumes that the tracer
washout is negligible. However to fully quantify the
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effect of anaesthesia on the tracer kinetics a dynamic
scan starting from the time of injection is necessary.
The third method, which does allow for dynamic scan-
ning, is to physically restrain the animals (particularly
the head for brain imaging) such that motion is impos-
sible [5]. In this case though the effect of stress on the
kinetics is another confounding factor which is diffi-
cult to quantify, and is known to affect brain function
in many cases [6, 7]. A novel method for conducting
brain scanning of conscious animals is the so-called
RatCAP [8, 9], where a miniaturised PET scanner is
surgically mounted directly onto the head of a rat and
thus moves rigidly with the brain, avoiding motion be-
tween the brain and the scanner. While this system is
promising it has a lower sensitivity than commercial
scanners and may inhibit the natural movement of the
rat, possibly inducing stress in the animal.
As stated in [2], a study involving fully awake, un-
restrained animals would be ideal for quantifying the
effect of an anaesthetic. Several groups, including our
own, have been conducting research into tracking the
head motion of an awake animal (usually a rat) during
a scan and correcting the PET data post-acquisition
according the measured motion, such that a recon-
struction can be made free of motion artefacts [10, 11].
Such motion compensation (MC) approaches avoid the
need for anaesthesia and minimise the stress of the an-
imal since it is unrestrained (although the animal is of-
ten confined to a small space during the scan). Motion
tracking can either be marker-based [10, 11], where a
small marker is attached to the head of the animal and
tracked by external cameras, or markerless, where the
facial features of the animal are identified and tracked
[12]. These approaches have been shown to produce
reconstructions of comparable quality to those of stan-
dard (anaesthetised) scans, and thus show the greatest
promise for investigating the effect of anaesthetics. In
[13] a preliminary study was presented on tracer kinet-
ics in a conscious and unrestrained rat, but otherwise,
to the best of our knowledge, no other studies have
been reported using this approach.
In this work we report on a study of fully con-
scious, tube-bound, but unrestrained, rats undergoing
dynamic scans to evaluate the effect of the anaesthe-
sia induced by isoflurane on 18F-FDG uptake in the
brain. An external stereo-optical system is used to
track a marker attached to the rat’s head [11, 14], and
a list-mode based motion compensation reconstruction
is then performed to achieve a reconstruction free of
motion artefacts [15].
This investigation was chiefly conducted as a proof-
of-principle study, and therefore we made use of 18F-
FDG since the effect of isoflurane on this tracer is
largely understood [2, 4]. We aim to confirm the re-
sults found by these previous studies, contribute to
the understanding of the effect of isoflurane by scan-
ning dynamically from the time of tracer infusion, and
to demonstrate the efficacy of motion compensation
in such studies. In the future we will conduct similar
studies on tracers where the effect of the anaesthetic
is not as well understood, and where a reference tis-
sue model exists such that kinetic modelling can be
performed without requiring arterial blood sampling.
2 Method
2.1 Hardware
PET measurements were performed using the mi-
croPET Focus 220 small animal PET scanner (Preclin-
ical Solutions, Siemens Healthineers, Knoxville, TN,
USA). To track the motion the MicronTracker Sx60
(ClaroNav Inc., Toronto, Canada) was used, as in [11].
The MicronTracker (MT) is a stereo-optical system
which tracks preregistered planar markers, deriving
the 6 degrees-of-freedom (i.e. the marker pose) from
two simultaneously acquired but spatially offset im-
ages. It was used to track a small marker (2.2 × 1.7
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Figure 1 (a) The MicronTracker in front of the microPET scanner. The large marker attached to the front of the scanner is the
reference marker used to aid in transforming from the MT coordinates to the microPET coordinates. (b) The head marker used in
rat studies. (c) An unrestrained rat with an attached head marker inside a tube within the microPET. The catheter port can be seen
between its shoulders. Figure reproduced with permission of IOP Publishing from [14]. c© Institute of Physics and Engineering in
Medicine. All rights reserved.
cm) attached to the rat’s head, at a frequency of 25 -
30 Hz. The experimental setup is shown in Fig. 1.
Spatial calibration Since the PET and MT coordi-
nate systems are not necessarily aligned to each other,
the transformation matrix to convert the recorded mo-
tion data into PET coordinates must be determined. A
similar procedure to that described in [16] and [17] was
used: a radioactive point source is placed on the origin
of an MT marker, and scanned and tracked at various
positions within the PET. The PET data were recon-
structed using the commercial software of the scanner.
By comparing the MT data with the PET reconstruc-
tions, it is possible to determine a suitable transforma-
tion between the coordinate systems [18]. A reference
marker attached to the PET gantry (see Fig. 1) allows
us to use the same calibration on different scan days
even if the MT has been moved.
Temporal calibration As each motion data point is
measured a pulse is sent to the PET gate input to
cause a tag to be inserted into the list-mode stream.
Aligning the recorded motion data with the gate tags
allows for the temporal calibration of the two data sets.
In previous work we have optimised the experimen-
tal setup parameters for the MT and microPET [14],
and the same parameters were utilised for this study.
Our hardware and software for MC have been quanti-
tatively validated using phantom measurements.
2.2 Experiment Protocol
All animal experiments were approved by the bioeth-
ical committee of the KU Leuven and performed in
accordance with the European Communities Council
Directive (86/609/EEC).
Five female Wistar rats were used (200 - 281 g), des-
ignated as “A - E”, three of which had repeat studies
(indicated by subscripts in their designations), yielding
eight data sets in total. Seven to ten days before the
start of the study a surgery was performed on each
rat to insert a catheter into the femoral vein, with
an access port protruding dorsally between the scapu-
lae[1]. Before the surgery medetomidine (0.3 mg/kg)
and ketamine (60 mg/kg) were administered to the
[1]One rat (not counted in the eight data sets) was
excluded from the study after it was established (post-
mortem) that the inserted catheter had come out of
the vein.
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Figure 2 The timeline of the experimental protocol for the (a) conscious and (b) unconscious studies, for each rat. Time 0 is when
the tracer was infused and the scan was started. For the time points with some spread the mean ± standard deviation is quoted.
Most rats followed the ideal protocol (first line), but there were some deviations for rats A, C1, C2, E2, and B, as can be seen.
rats via an intraperitoneal injection. Following this the
rats were put on a 3 day course of antibiotics and anal-
gesics. After recovery, each rat was then acclimatised
to having the marker attached to its head, as well as
being unrestrained inside a tube in the scanner, over
a period of 3 days leading up to the scan for 30 min-
utes initially and increasing to 60 minutes. Since the
rat was not restrained it was possible for it to exit the
tube onto the scanner gantry since the tube is approx-
imately 10 cm above the scanner bore. If this occurred
the rat was then manually placed back in the tube,
and made fewer attempts to exit the tube as the days
progressed. During scans, three of the rats did exit the
tube once and were replaced in the tube immediately,
but since their head motion was being tracked this
had no effect on the final reconstruction, except for a
short period were no PET data were acquired, which
is automatically corrected for during reconstruction as
explained in section 2.3.
On the first day of the acclimatisation (3 days before
the scan) the rats were anaesthetised with isoflurane
for approximately 15 minutes to have the fur on their
forehead removed for better marker attachment. The
marker was attached to the rat’s forehead using “su-
perglue”, which bonds and dries rapidly, but does not
irritate the skin of the rat, thereby minimising discom-
fort, and which comes off by itself after several days.
The marker and tube can be seen in Fig. 1(c). When-
ever used, isoflurane was administered with a concen-
tration of 2.5% in 2 L/min O2.
A schematic of the experimental protocol is shown
in Fig. 2; a pre-determined protocol was used for the
rats, but there were some deviations (as can be seen
in Fig. 2) due to unforeseen circumstances beyond our
control, but nonetheless these did not invalidate any
of the data sets.
It is known that there are many factors which can af-
fect FDG uptake [19, 20, 21] such as the blood glucose
level, muscle usage, tracer administration route, body
temperature, stress, etc., and so where possible these
were minimised or kept consistent across the rats. Pre-
ceding the scans the rats were fasted overnight for 12 -
15 hours, with free access to water [22]. The rats were
scanned while conscious for 60 - 75 minutes, starting
from the tracer infusion. The tracer was infused via
the intra-femoral vein catheter with 20 - 30 MBq of
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18F-FDG in a total injected volume of 0.8 mL (includ-
ing saline for flushing) using an infusion pump over
25 seconds. Immediately following this scan the rats
were anaesthetised with isoflurane and scanned for an
additional 10 minutes while unconscious, to provide a
validation of the MC reconstruction of the last frame
of the conscious scan since the activity distribution in
these reconstructions should be very similar. Two to
three days after the conscious scan the rats were again
fasted and scanned with the same procedure, but while
anaesthetised with isoflurane, which was administered
before the tracer infusion and constantly throughout
the scan. During all unconscious scans the rats were
placed on a heated mat to maintain body temperature.
As suggested in [22] the blood glucose level of each rat
was measured before and after each scan in duplicate
using a drop of venal blood from a tail prick, with the
GlucoCard Memory 2 meter (A. Menarini Diagnostics
S.r.l., Florence, Italy), with exceptions being rat C1
where no reading was taken before the conscious scan,
and rats C2, D1, and E1 where the readings were not
taken in duplicate for the conscious scans.
While rat stress is a difficult factor to quantify, a
similar set up was used by Fulton et al. [23] where
body temperature was measured as a stress indica-
tor using peritoneally implanted temperature sensors;
Fulton et al. found that the body temperature did not
elevate to levels indicative of stress while the rats were
in the tube for up to 60 minutes. In our experiments
the rats exhibited no observable behavioural signs of
stress: they engaged in grooming, resting, and explor-
ing their (limited) surroundings.
2.3 Reconstruction
After correcting each of the list-mode events’ end-
points according to the recorded motion, the recon-
structions were performed using list-mode ordered sub-
sets expectation-maximisation (OSEM) [24, 25, 26,
27], using 10 iterations and 10 subsets, and a pixel
size of [0.475, 0.475, 0.798] mm. The resolution was
modelled using an image-based convolution [28] with
a Gaussian kernel with a FWHM of 1.3 mm [29]. An at-
tenuation map was constructed by extracting the body
contour of the rat from a preliminary reconstruction
(without attenuation correction) and filling it with the
attenuation coefficient of soft tissue, ignoring the skull
since it is very thin [30]. As suggested by [15], the data
were pre-corrected for attenuation, and the sensitiv-
ity image was calculated as a weighted average of all
poses. By analysing a reconstruction of an unconscious
rat scan, it was established that the effect of scatter
on the brain was less than 2.5%, and of randoms was
around 1%, which was sufficiently small to ignore in
the reconstructions.
If the rat temporarily moved out of the scanner field-
of-view (such as in the few occurrences where the rat
exited the tube), and whenever motion data was not
available because, for example, the rat moved its head
to an orientation where the marker could not be seen
by the tracker, then the time-averaged sensitivity im-
age would automatically have a zero contribution from
those time points, and thus would automatically scale
the reconstruction to correct for these periods. In the
latter case any PET data acquired during these peri-
ods were ignored.
The rats were observed to touch the marker inter-
mittently 1 - 4 times during the scans, and four rats
managed to move the marker and cause some rela-
tive motion between the marker and the brain, which
resulted in inter- and intra-frame motion in the re-
constructions. Inter-frame motion was corrected for
by frame-by-frame registration (after selecting a refer-
ence frame and ignoring early frames with low uptake).
While this was necessary in only four of the studies
(in the worst case resulting in a shift of about 3 mm
within the brain over two frames), it was performed by
default. Intra-frame motion of the marker relative to
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the brain would result in residual motion blur in the
reconstructed image.
The unconscious and conscious scan reconstructions
were aligned by an affine registration to the John-
son rat brain atlas [31], which was used to delineate
regions-of-interest (ROIs). Since no arterial blood sam-
pling could be performed on the conscious rats, and
FDG has no reference tissue model in the rat brain,
no input function could be derived and therefore the
tracer kinetics could not be modelled.
2.4 Data Analysis
After correcting for deadtime and decay, the standard
uptake values (SUVs) were calculated for each recon-
struction using,
SUVj = Λj
w
d
, (1)
where Λj is the reconstructed activity concentration in
pixel j, w is the rat’s body weight, and d is the injected
dose.
Due to the variability in the glucose levels (as dis-
cussed in 3.1), the data analysis was performed by cal-
culating the ratio of various ROIs to the whole brain
average. Such ratios are thus not affected by the scaling
by the glucose level and yield information regarding
how the regional distribution of the tracer was affected
by the isoflurane. The ratios were calculated using,
Rrik =
Λ¯rik
Λ¯0ik
, (2)
where r, i, and k are the ROI, frame, and rat indices,
respectively, Λ¯rik is the mean value of the pixels inside
the ROI r, and where r = 0 indicates the whole brain
ROI. The ROIs considered were the cortex, cerebel-
lum, diencephalon, striata, vestibular nuclei, and in-
ferior colliculi, shown in Fig. 6(a) and (b). The mean
ratios across the rats are then denoted by R¯ri.
Since each rat was scanned with and without the
anaesthetic they can be considered to be their own con-
trols. A paired t-test between the unconscious and con-
scious scans was conducted on the ratios of six ROIs
under consideration (using a Bonferroni correction fac-
tor of 6), at equilibrium, i.e. the sum of the last five
frames spanning from 38 minutes to 75 minutes post-
injection.
3 Results & Analysis
3.1 Blood glucose level
The blood glucose measurements taken before and
after each of the scans have been summarised in Fig. 3.
For the conscious scans the glucose level was relatively
constant from before to after the scan across the rats,
falling within a range of [3.3, 5.0] mmol/L. During the
unconscious scans, on the other hand, the glucose lev-
els were often very different from before to after the
scan, and exhibited a greater range across the rats,
falling within [1.7, 6.2] mmol/L. For all unconscious
scans, except E1, the glucose level rose, some substan-
tially, from before to after the scan, while for E1 it
dropped. This indicates an effect of the anaesthetic
on the glucose level. Significant responses of the glu-
cose level to isoflurane have been reported by other
groups; an increase in the blood glucose level in the
brain was observed for adult rats in [32] and [33] after
60 to 75 minutes of isoflurane, while in neonatal mice
a decrease in the glucose level was observed in [34].
An increase in glucose level was also observed in hu-
mans administered with isoflurane, and it is thought
that this may be due to a decreased insulin response
[35]. These effects all suggest that glucose regulation is
affected by isoflurane, which is a further confounding
factor in studies involving isoflurane.
Due to this variation of the glucose level it was
not evident which measurement (before, after, or the
mean) should be used to normalise the reconstructions,
as suggested in [22]. Therefore it was decided to anal-
yse relative changes in the uptake of FDG in the rat
brain, which are independent of the glucose level, for
Spangler-Bickell et al. Page 7 of 13
A B C1 C2 D1 D2 E1 E2
Rat
0
2
4
6
8
G
lu
co
se
 le
ve
l (
m
m
ol
/L
)
G
lu
co
se
 le
ve
l (
m
m
ol
/L
)
* *
*
*
**
Unconscious
Conscious
Figure 3 Blood glucose level measurements for each rat at the time of the unconscious (black) and conscious (red) scans. For each
rat, the arrows start at the measurements taken before the scan and end at those taken after the scan. Most measurements were
taken in duplicate, the extent of which are indicated by the dark grey bars. *Only a single measurement was taken. **No
measurement was taken before the scan.
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Figure 4 The translations (a) and rotations (b) of a rat’s head during a 10 minute conscious scan. (c) Non-MC (left) and MC
(middle) reconstructions of the conscious scan, which started 60 minutes after tracer injection, along with a reconstruction (right) of
an unconscious scan of 10 minutes taken of the same rat, 91 minutes after tracer injection. The dashed lines indicate where the
image slices are located. (d) A selection of dynamic frames from the unconscious (top) and conscious (bottom) scan reconstructions,
averaged over all eight data sets. The times below the frames indicate the frame start time since the tracer injection.
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Figure 5 TACs for all eight data sets for the whole brain ROI, for the conscious (dotted lines) and unconscious (solid lines) scans, as
well as the static scan with anaesthesia following the conscious scan (square points). The data sets are divided over two plots for
clarity. For rats B and D2 the static scan data was not available. No error bars are plotted since the ROI is non-uniform.
Table 1 Average ratio between ROIs and whole brain at equilibrium
Uncon. Con. Change ± SD (%) p Sig.
Cortex 0.90 1.06 18.2± 7.1 7.4× 10−5 Yes
Vestibular Nu. 1.57 1.10 −29.5± 6.2 2.7× 10−5 Yes
Diencephalon 1.10 1.22 10.3± 4.7 0.0004 Yes
Inf. Colliculi 1.20 1.26 5.3± 3.4 0.0030 Yes
Cerebellum 1.05 1.00 −3.7± 8.9 0.2322 No
Striata 1.12 1.15 3.7± 8.0 0.2920 No
the various ROIs, as shown in equation (2). In addi-
tion, however, a comparison of the whole brain average
in the conscious and unconscious scans was also con-
ducted.
3.2 Reconstructions
The measured motion of a conscious rat during a 10
minute scan is shown in Fig. 4(a) and (b), with the
MC reconstruction in 4(c) along with the subsequent
unconscious scan reconstruction. Much of the resolu-
tion lost due to the motion has been recovered, and
the activity distribution is very similar between the
conscious and unconscious scan reconstructions. Since
the rat moved significantly during the scan the activity
concentration is much lower in the non-MC reconstruc-
tion, however the total activity is approximately equal
to the MC reconstruction, as expected.
A selection of the dynamic frames for the average of
the eight data sets is shown in Fig. 4(d) for the con-
scious and unconscious scans. In Fig. 5 the time ac-
tivity curves (TACs) for the whole brain region for all
eight data sets is shown. The unconscious, static scans
taken after the conscious scans are in good agreement
with the last frames of the conscious scans, possibly
showing some degree of washout [36], a trend which is
observable in the last few frames of the dynamic scan.
To investigate whether there was a correlation be-
tween the SUVs and glucose levels, a Pearson product-
moment correlation analysis was conducted on the
SUVs at equilibrium (i.e. the sum of the last five
frames) versus both the pre- and post-scan glucose lev-
els. In the conscious case the correlation coefficients
were -0.19 and -0.28 for the pre- and post-scan glucose
level, respectively, (indicating no correlation) and in
Spangler-Bickell et al. Page 9 of 13
Conscious Unconscious Conscious Unconscious
0 10 20 30 40 50 60 70 80 90 100
Time (min)
0.8
1.0
1.2
1.4
R
Whole brain
Cortex
Cerebellum
Diencephalon
Unconscious
Conscious
Static after conscious
0 10 20 30 40 50 60 70 80 90 100
Time (min)
0
1
2
3
4
5
6
7
SU
V
Whole brain
Striatum
Vestibular nu
Inf colliculus
Unconscious
Conscious
Static after conscious
0 10 20 30 40 50 60 70 80 90 100
Time (min)
0
1
2
3
4
5
6
7
SU
V
Cortex
Cerebellum
Diencephalon
Unconscious
Conscious
Static after conscious
0 10 20 30 40 50 60 70 80 90 100
Time (min)
0.8
1.0
1.2
1.4
1.6
1.8
2.0
R
Whole brain
Striatum
Vestibular nu
Inf colliculus
Unconscious
Conscious
Static after conscious
(f)(e)
(c)
(a)
(d)
(b)
Figure 6 (a) and (b) The ROIs under consideration are indicated on the last frame from the average of the eight reconstructions. (c)
and (d) TACs for various ROIs for the average of the eight data sets, for the conscious (dotted lines) and unconscious (solid lines)
scans, as well as the static scan with anaesthesia following the conscious scan (square points). The overlapping error bars are
staggered for clarity. (e) and (f) The ratio of various ROIs to the whole brain average, averaged over the eight data sets. In all plots
the error bars are the standard deviations across the data sets and are only shown in two representative locations for clarity.
the unconscious case they were 0.62 and 0.53 for the
pre- and post-scan glucose level, respectively. However,
the p-values for these fits were higher than 0.05 and
therefore there is insufficient evidence to conclude that
a correlation exists between the SUVs and the glucose
levels.
A paired t-test was performed on the SUVs at
equilibrium for the whole brain region to determine
whether the uptake in that ROI was significantly dif-
ferent between the conscious and unconscious scans.
The change from unconscious to the conscious scan
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had a mean of 59 ± 52%, and the p-value of the test
was 0.007, which is significant at the p < 0.05 level.
The TACs for the six ROIs for the average of the
eight data sets are shown in Fig. 6(c) and (d). Plots
of the ratios between each of the ROIs and the whole
brain average are shown in Fig. 6(e) and (f). Again, the
unconscious, static scans show good agreement with
the last frames of the conscious scan. The results of the
paired t-test analysis on the ROI ratios at equilibrium
are summarised in Table 1. For the conscious scans, the
relative changes in the cortex (18.2 ± 7.1%), vestibu-
lar nuclei (−29.5± 6.2%), diencephalon (10.3± 4.7%),
and inferior colliculi (5.3 ± 3.4%) compared to the
unconscious scan were significant with p < 0.05 (i.e.
p < 0.008 after the Bonferroni correction). No signif-
icant changes (at the same p-level) were observed in
the cerebellum and striata.
4 Discussion
In this study we have demonstrated the efficacy of us-
ing a motion compensation technique to study fully
conscious and unrestrained rats in a dynamic study.
We investigated the effect of the anaesthetic isoflurane
on the uptake of FDG in the rat brain, and a clear and
significant impact of the isoflurane on the regional dis-
tribution of FDG uptake in the rat brain was observed.
From the blood glucose level measurements before
and after the scans, we observed a large variability
in the glucose levels of the unconscious rats, and a
substantial change in the glucose level from before to
after the scan, which is in agreement with other re-
ported studies [32, 33]. In one test-retest (for rat E) the
behaviour of the glucose level was not consistent. No
statistical correlation was found between the SUVs at
equilibrium and the glucose levels. Therefore, if a glu-
cose correction is to be performed on the SUVs when
using isoflurane then this variability must be taken into
consideration. On the other hand, the glucose levels of
the conscious rats were much more constant from be-
fore to after the scan, and between different rats.
Even though the conscious rats exhibited a large
range of motion during the scan, the data were suc-
cessfully compensated for motion and much of the res-
olution lost was regained. All of the rats tolerated the
acclimatisation and scanning very well, with only three
actually exiting the tube during a scan (before being
placed back in the tube) which did not adversely af-
fect the reconstructions. On occasion some rats did try
to remove the marker during the scan, thus possibly
inducing relative motion between the marker and the
brain. This resulted in some inter- and intra-frame mo-
tion, the former of which was corrected for by frame-
by-frame registration, and the latter possibly causing
some residual motion blur in the reconstructions. The
motion compensation was verified by comparing the
last frame of the conscious scan to the subsequent,
static, unconscious scan.
Since no blood input function could be measured for
the conscious rats, and FDG has no reference tissue
model in rats, a full kinetic analysis could not be per-
formed. Nonetheless, from the results of the dynamic
scans presented in Fig. 5 and 6 it is clear that the isoflu-
rane has a substantial impact on the tracer uptake. A
paired t-test confirmed that there was a significant dif-
ference between the whole brain SUVs at equilibrium
in the conscious and unconscious scans (p < 0.05).
Furthermore, an analysis of the regional distributions
within the brain showed a significant difference in the
cortex, diencephalon, vestibular nuclei, and inferior
colliculi between the conscious and unconscious scans
(p < 0.05). Previously, Matsumura et al. [4] conducted
a study into the effect of various anaesthetics (includ-
ing isoflurane) on FDG uptake in rats. They acquired
static images of anaesthetised rats after allowing for
a conscious uptake period and found similar regional
differences to those found in this study: a decrease in
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the frontal cortex (although with a smaller magnitude
increase in the posterior cerebral cortex), a decrease in
the thalamus (a substructure of the diencephalon), and
no change in the cerebellar cortex (a substructure of
the cerebellum) and the striata. Their approach, unlike
that presented in this work, cannot be used to investi-
gate the effect of anaesthesia on tracer kinetics, which
requires dynamic scanning from the time of injection.
In the unconscious scans there was a strong contrast
between the vestibular nuclei and the whole brain,
while this contrast was not observed in the conscious
scans. In [37] Gupta et al. investigated the effect of
isoflurane on the vomiting reflex. They used musk
shrews instead of rats since the latter do not exhibit
a vomiting reflex (however the rat brain may nonethe-
less respond similarly to isoflurane). They found that
isoflurane induced a high c-Fos cell count (a protein
related to neuronal activity) in the vestibular nuclei,
where vestibular inputs are integrated with inputs
from other sensory systems and the cerebellum for the
perception of balance. High neuronal activity in the
vestibular nuclei would likely be accompanied by an
increased glucose uptake, explaining the high FDG up-
take in the vestibular nuclei in the unconscious scans
compared to the whole brain average.
5 Conclusion
The effect of isoflurane on the uptake of FDG in the
rat brain has been investigated using a motion com-
pensation technique to scan fully conscious and un-
restrained rats dynamically from the time of tracer
infusion. Although relatively few animals were stud-
ied, since each animal could be considered to be its
own control, our results show a clear and significant
impact of the isoflurane on the regional distribution
of FDG in the rat brain. A significant difference was
observed in the cortex, diencephalon, vestibular nu-
clei, and inferior colliculi, while no significant effect
was observed in the cerebellum and striata. A strong
variability was observed in the blood glucose levels of
the anaesthetised rats between scans, and from before
to after the scan, which suggests that this could be a
further confounding factor of isoflurane on FDG stud-
ies. This work demonstrates that if isoflurane is to be
used in FDG studies, these confounding factors should
be recognised and taken into account.
In the future we will perform similar studies on other
common PET tracers, especially those with a refer-
ence tissue model where kinetic modelling can be per-
formed, such as raclopride or fallypride. For many such
tracers the influence of anaesthesia is not completely
understood.
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